Several CWIMS events in the near future will fortify the group’s mission to connect and collaborate with a variety of audiences.

Michael Kyba, PhD, Darko Bosnakovski, DVM, PhD, and their team discovered a way to deactivate DUX4 and take away the toxic effects in cells, as well as in a mouse model for FSHD.

New research has shown that survival outcomes for pediatric cancer patients after an organ transplant were very promising and appeared similar to general outcomes. This study demonstrated it is a viable option for physicians and insurance companies to consider when making a decision.